Works matching AU Chang, Ting‐Tsung


Results: 60
    1
    2

    The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer.

    Published in:
    Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01182-5
    By:
    • Hsiao, Kai-Ching;
    • Ruan, Siou-Ying;
    • Chen, Shih-Min;
    • Lai, Tai-Yu;
    • Chan, Ren-Hao;
    • Zhang, Yan-Ming;
    • Chu, Chien-An;
    • Cheng, Hung-Chi;
    • Tsai, Hung-Wen;
    • Tu, Yi-Fang;
    • Law, Brian K.;
    • Chang, Ting-Tsung;
    • Chow, Nan-Haw;
    • Chiang, Chi-Wu
    Publication type:
    Article
    3
    4
    5
    6
    7

    Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48500-y
    By:
    • Lin, Selena Y.;
    • Xia, Wei;
    • Kim, Amy K.;
    • Chen, Dion;
    • Schleyer, Shelby;
    • Choi, Lin;
    • Wang, Zhili;
    • Hamilton, James P.;
    • Luu, Harry;
    • Hann, Hie-Won;
    • Chang, Ting-Tsung;
    • Hu, Chi-Tan;
    • Woodard, Abashai;
    • Gade, Terence P.;
    • Su, Ying-Hsiu
    Publication type:
    Article
    8
    9
    10
    11
    12

    Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 7, p. 1323, doi. 10.1111/jgh.13305
    By:
    • Chuang, Wan‐Long;
    • Chien, Rong‐Nan;
    • Peng, Cheng‐Yuan;
    • Chang, Ting‐Tsung;
    • Lo, Gin‐Ho;
    • Sheen, I‐Shyan;
    • Wang, Horng‐Yuan;
    • Chen, Jyh‐Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Gao, Bing;
    • Garrison, Kimberly L.;
    • Mo, Hongmei;
    • Pang, Phillip S.;
    • Hsu, Yu‐Chun;
    • Hu, Tsung‐Hui;
    • Chu, Chi‐Jen;
    • Kao, Jia‐Horng
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 8, p. 1101, doi. 10.1111/liv.13082
    By:
    • Kao, Jia ‐ Horng;
    • Chien, Rong ‐ Nan;
    • Chang, Ting ‐ Tsung;
    • Peng, Cheng ‐ Yuan;
    • Hu, Tsung ‐ Hui;
    • Lo, Gin ‐ Ho;
    • Wang, Horng ‐ Yuan;
    • Chen, Jyh ‐ Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Han, Lingling;
    • Mo, Hongmei;
    • Mathias, Anita;
    • Brainard, Diana M.;
    • Sheen, I ‐ Shyan;
    • Hsu, Yu ‐ Chun;
    • Chu, Chi ‐ Jen;
    • Chuang, Wan ‐ Long
    Publication type:
    Article
    19
    20

    Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study).

    Published in:
    Infectious Diseases & Therapy, 2025, v. 14, n. 5, p. 1089, doi. 10.1007/s40121-025-01145-y
    By:
    • Huang, Chung-Feng;
    • Heo, Jeong;
    • Chien, Rong-Nan;
    • Baek, Yang-Hyun;
    • Kao, Jia-Horng;
    • Kim, Ju-Hyun;
    • Chang, Ting-Tsung;
    • Byun, Kwan-Soo;
    • Chen, Jyh-Jou;
    • Jeong, Sook-Hyang;
    • Hu, Tsung-Hui;
    • Kim, Young-Seok;
    • Peng, Cheng-Yuan;
    • Tak, Won-Young;
    • Wang, Horng-Yuan;
    • Yoon, Seung-Kew;
    • Sheen, I.-Shyan;
    • Youn-Jae Lee;
    • Hsu, Yu-Chun;
    • Yim, Hyung-Joon
    Publication type:
    Article
    21

    Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.

    Published in:
    Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 12, p. 1998, doi. 10.1111/jgh.13796
    By:
    • Kao, Jia‐Horng;
    • Yu, Ming‐Lung;
    • Peng, Cheng‐Yuan;
    • Heo, Jeong;
    • Chu, Chi‐Jen;
    • Chang, Ting‐Tsung;
    • Lee, Youn‐Jae;
    • Hu, Tsung‐Hui;
    • Yoon, Ki Tae;
    • Paik, Seung Woon;
    • Lim, Young Suk;
    • Ahn, Sang Hoon;
    • Isakov, Vasily;
    • McPhee, Fiona;
    • Hu, Wenhua;
    • Scott Swenson, Eugene;
    • Yin, Philip D;
    • Treitel, Michelle
    Publication type:
    Article
    22

    Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 3, p. 854, doi. 10.3390/cancers15030854
    By:
    • Chiang, Hsueh-Chien;
    • Lee, Yang-Cheng;
    • Chang, Ting-Tsung;
    • Lin, Yih-Jyh;
    • Wu, Hung-Tsung;
    • Wang, Chung-Teng;
    • Chen, Chiung-Yu;
    • Chen, Po-Jun;
    • Hsieh, Ming-Tsung;
    • Lin, Sheng-Hsiang;
    • Chen, Shang-Hung;
    • Chuang, Chiao-Hsiung;
    • Wu, I-Chin;
    • Hong, Tzu-Chun;
    • Wu, Juei-Seng;
    • Han, Meng-Zhi;
    • Chen, Wei-Ting;
    • Chiang, Chien-Ming;
    • Hung, Kuan-Kai;
    • Kuo, Hsin-Yu
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.

    Published in:
    Clinical Infectious Diseases, 2022, v. 75, n. 3, p. 453, doi. 10.1093/cid/ciab971
    By:
    • Liu, Chun Jen;
    • Sheen, I Shyan;
    • Chen, Chi Yi;
    • Chuang, Wan Long;
    • Wang, Horng Yuan;
    • Tseng, Kuo Chih;
    • Chang, Ting Tsung;
    • Yang, Jenny;
    • Massetto, Benedetta;
    • Suri, Vithika;
    • Camus, Gregory;
    • Jiang, Deyuan;
    • Zhang, Fangqiu;
    • Gaggar, Anuj;
    • Hu, Tsung Hui;
    • Hsu, Yu Chun;
    • Lo, Gin Ho;
    • Chu, Chi Jen;
    • Chen, Jyh Jou;
    • Peng, Cheng Yuan
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settings.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359241312141
    By:
    • Chiang, Chien-Ming;
    • Huang, Kuan-Kai;
    • Lee, Chun-Te;
    • Hong, Tzu-Chun;
    • Wu, Juei-Seng;
    • Wu, Hung-Tsung;
    • Chang, Ting-Tsung;
    • Liu, Yi-Sheng;
    • Chen, Wei-Ting;
    • Wang, Chung-Teng;
    • Chang, Chen;
    • Chen, Po-Jun;
    • Hsieh, Ming-Tsung;
    • Chen, Chiung-Yu;
    • Chuang, Chiao-Hsiung;
    • Lee, Ching-Chi;
    • Lin, Sheng-Hsiang;
    • Lin, Yih-Jyh;
    • Kuo, Hsin-Yu
    Publication type:
    Article
    38
    39

    Urine DNA biomarkers for hepatocellular carcinoma screening.

    Published in:
    2022
    By:
    • Kim, Amy K.;
    • Hamilton, James P.;
    • Lin, Selena Y.;
    • Chang, Ting-Tsung;
    • Hann, Hie-Won;
    • Hu, Chi-Tan;
    • Lou, Yue;
    • Lin, Yih-Jyh;
    • Gade, Terence P.;
    • Park, Grace;
    • Luu, Harry;
    • Lee, Tai-Jung;
    • Wang, Jeremy;
    • Chen, Dion;
    • Goggins, Michael G.;
    • Jain, Surbhi;
    • Song, Wei;
    • Su, Ying-Hsiu
    Publication type:
    journal article
    40
    41
    42
    43

    Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma.

    Published in:
    Pharmaceutics, 2022, v. 14, n. 11, p. 2263, doi. 10.3390/pharmaceutics14112263
    By:
    • Kuo, Hsin-Yu;
    • Han, Meng-Zhi;
    • Liao, Chih-Hsiang;
    • Lin, Yih-Jyh;
    • Wang, Chung-Teng;
    • Chen, Shang-Hung;
    • Chang, Ting-Tsung;
    • Chen, Po-Jun;
    • Lin, Sheng-Hsiang;
    • Chen, Chiung-Yu;
    • Chuang, Chiao-Hsiung;
    • Wu, I-Chin;
    • Wu, Juei-Seng;
    • Hong, Tzu-Chun;
    • Hsieh, Ming-Tsung;
    • Lee, Yang-Cheng;
    • Wu, Hung-Tsung;
    • Tsai, Hong-Ming
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50